scholarly article | Q13442814 |
P356 | DOI | 10.1021/JM0111043 |
P698 | PubMed publication ID | 11960491 |
P2093 | author name string | Evi Kostenis | |
Michael Kurz | |||
Alain Fournier | |||
Thomas Klabunde | |||
Stefanie Flohr | |||
Alexandre Brkovich | |||
P433 | issue | 9 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | virtual screening | Q4112105 |
P304 | page(s) | 1799-1805 | |
P577 | publication date | 2002-04-01 | |
P1433 | published in | Journal of Medicinal Chemistry | Q900316 |
P1476 | title | Identification of nonpeptidic urotensin II receptor antagonists by virtual screening based on a pharmacophore model derived from structure-activity relationships and nuclear magnetic resonance studies on urotensin II. | |
P478 | volume | 45 |
Q73313937 | A Combinatorial Scaffold Approach Based upon a Multicomponent Reaction |
Q40703439 | A new ligand for the urotensin II receptor |
Q28478109 | A novel structural framework for α(1A/D)-adrenoceptor selective antagonists identified using subtype selective pharmacophores |
Q37737587 | A rat brain atlas of urotensin-II receptor expression and a review of central urotensin-II effects |
Q34985885 | An overview on GPCRs and drug discovery: structure-based drug design and structural biology on GPCRs |
Q42667921 | Behavioral effects of urotensin-II centrally administered in mice |
Q28260943 | Biochemical and functional characterization of high-affinity urotensin II receptors in rat cortical astrocytes |
Q76383741 | Cardiovascular actions of human urotensin II--considerations for hypertension |
Q54708765 | Cellular distribution of GPR14 and the positive inotropic role of urotensin II in the myocardium in adult rat. |
Q34479147 | Comparative genomics provides evidence for close evolutionary relationships between the urotensin II and somatostatin gene families |
Q42069892 | Construction of a sequence motif characteristic of aminergic G protein-coupled receptors |
Q42004371 | De novo molecular modeling and biophysical characterization of Manduca sexta eclosion hormone |
Q31035828 | Directed sorting approach for the synthesis of large combinatorial libraries of discrete compounds |
Q90650682 | Discovery of Novel Glucagon Receptor Antagonists Using Combined Pharmacophore Modeling and Docking |
Q35033297 | Emerging roles for orphan G-protein-coupled receptors in the cardiovascular system |
Q37388375 | G protein-coupled receptors: in silico drug discovery in 3D. |
Q35047377 | Identification and pharmacological characterization of native, functional human urotensin-II receptors in rhabdomyosarcoma cell lines |
Q35997019 | In silico design and analysis of a new hyperglycosylated analog of erythropoietin to improve drug efficacy |
Q35995265 | In silico pharmacology for drug discovery: applications to targets and beyond |
Q36840592 | In silico pharmacology for drug discovery: methods for virtual ligand screening and profiling |
Q48675996 | Localization of the urotensin II receptor in the rat central nervous system |
Q51552963 | New QSAR prediction models derived from GPCR CB2-antagonistic triaryl bis-sulfone analogues by a combined molecular morphological and pharmacophoric approach. |
Q44114224 | New insight into the binding mode of peptides at urotensin-II receptor by Trp-constrained analogues of P5U and urantide |
Q26772046 | Pharmacophore Models and Pharmacophore-Based Virtual Screening: Concepts and Applications Exemplified on Hydroxysteroid Dehydrogenases |
Q41981084 | Photolabelling the rat urotensin II/GPR14 receptor identifies a ligand-binding site in the fourth transmembrane domain. |
Q46248274 | Predicted ligands for the human urotensin-II G protein-coupled receptor with some experimental validation |
Q42397196 | Prediction of the three-dimensional structure for the rat urotensin II receptor, and comparison of the antagonist binding sites and binding selectivity between human and rat receptors from atomistic simulations |
Q36902874 | Role of urotensin II and its receptor in health and disease |
Q37737495 | Role of urotensin II in health and disease |
Q34012132 | Small molecule chemokine mimetics suggest a molecular basis for the observation that CXCL10 and CXCL11 are allosteric ligands of CXCR3 |
Q58855647 | Structure-Activity Study of the Peptides P5U and Urantide by the Development of Analogues Containing Uncoded Amino Acids at Position 9 |
Q44564935 | Structure-activity relationships of human urotensin II and related analogues on rat aortic ring contraction |
Q40644520 | The neuromedin B receptor antagonist, BIM-23127, is a potent antagonist at human and rat urotensin-II receptors |
Q36760529 | Therapeutic potential of blockade of the urotensin II system in systemic hypertension |
Q54414485 | Urantide conformation and interaction with the urotensin-II receptor. |
Q38093584 | Urotensin-II Ligands: An Overview from Peptide to Nonpeptide Structures |
Q35779239 | Urotensin-II and the cardiovascular system--the importance of developing modulators |
Q50992476 | Urotensin-II peptidomimetic incorporating a non-reducible 1,5-triazole disulfide bond reveals a pseudo-irreversible covalent binding mechanism to the urotensin G-protein coupled receptor. |
Q39039151 | Urotensin-II receptor is over-expressed in colon cancer cell lines and in colon carcinoma in humans. |
Search more.